GLUCAGON SELECTIVELY INCREASES SPLANCHNIC BLOOD-FLOW IN PATIENTS WITH WELL-COMPENSATED CIRRHOSIS

被引：43

作者：

LEE, SS ^{[1
]}

MOREAU, R ^{[1
]}

HADENGUE, A ^{[1
]}

CERINI, R ^{[1
]}

KOSHY, A ^{[1
]}

LEBREC, D ^{[1
]}

机构：

[1] HOP BEAUJON,INSERM,UNITE RECH PHYSIOPATHOL HEPAT U24,F-92118 CLICHY,FRANCE

来源：

HEPATOLOGY | 1988年 / 8卷 / 06期

关键词：

D O I：

10.1002/hep.1840080606

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：1501 / 1505

页数：5

共 50 条

[31] MORPHINE EFFECTS ON SPLANCHNIC AND CORONARY BLOOD-FLOW [J].

LEAMAN, DM ;

LEVENSON, LW ;

SHIROFF, RA ;

NELLIS, SH ;

GRAVES, K ;

ZELIS, R .

CLINICAL RESEARCH, 1976, 24 (03) :A226-A226

[32] INCREASING SPLANCHNIC BLOOD-FLOW IN THE CRITICALLY ILL [J].

MAYNARD, ND ;

BIHARI, DJ ;

DALTON, RN ;

SMITHIES, MN ;

MASON, RC .

CHEST, 1995, 108 (06) :1648-1654

[33] THE EFFECT OF GIP ON SPLANCHNIC AND SYSTEMIC BLOOD-FLOW [J].

ANDERSEN, DK ;

ZENILMAN, ME ;

DENOY, DJ ;

WALDRON, RP ;

ZINNER, MJ .

GASTROENTEROLOGY, 1982, 82 (05) :1008-1008

[34] SPLANCHNIC BLOOD-FLOW AND FEEDING IN THE NEONATAL CALF [J].

DOBSON, A ;

GLEED, RD ;

TENNANT, BC .

FEDERATION PROCEEDINGS, 1984, 43 (04) :1011-1011

[35] THE EFFECTS OF INDOMETHACIN AND HEMORRHAGE ON SPLANCHNIC BLOOD-FLOW [J].

GERKENS, J ;

FAUST, T ;

BRANCH, R .

EUROPEAN JOURNAL OF PHARMACOLOGY, 1982, 78 (01) :81-90

[36] The renal sympathetic and renin-angiotensin response to lower body negative pressure in well-compensated cirrhosis [J].

Wong, F ;

Sniderman, K ;

Blendis, L .

GASTROENTEROLOGY, 1998, 115 (02) :397-405

[37] BASELINE CHARACTERISTICS IN WELL-COMPENSATED NASH CIRRHOSIS PATIENTS DIAGNOSED WITH OR WITHOUT A LIVER BIOPSY IN MAESTRO-NASH-OUTCOMES, A CLINICAL OUTCOME PHASE 3 STUDY ASSESSING THE EFFECT OF RESMETIROM IN WELL COMPENSATED NASH CIRRHOSIS [J].

Bansal, Meena ;

Schattenberg, Joern ;

Kowdley, Kris ;

Noureddin, Mazen ;

Loomba, Rohit ;

Taub, Rebecca ;

Labriola, Dominic ;

Schneider, David .

HEPATOLOGY, 2024, 80 :S645-S647

[38] Baseline characteristics in well-compensated NASH cirrhosis patients diagnosed with or without a liver biopsy in MAESTRO-NASH-OUTCOMES, a clinical outcome phase 3 study assessing the effect of resmetirom in well compensated NASH cirrhosis [J].

Schattenberg, Joern M. ;

Bansal, Meena ;

Taub, Rebecca ;

Labriola, Dominic ;

Schneider, David ;

Charlton, Michael ;

Ratziu, Vlad ;

Noureddin, Mazen .

JOURNAL OF HEPATOLOGY, 2025, 82

[39] Lactobacillus Casei Shirota (LCS; Yakult) vs Placebo in patients with well-compensated cirrhosis: A double-blind, randomized controlled study [J].

Macnaughtan, Jane ;

Lopez, Elisabet Garcia ;

Lu, Winston ;

Jones, Helen ;

Sawhney, Rohit ;

Marsden, Joanne ;

Davies, Nathan ;

Cox, I. Jane ;

Wright, Gavin ;

Thomas, Linda ;

Mookerjee, Rajeshwar ;

Jalan, Rajiv .

HEPATOLOGY, 2017, 66 :449A-449A

[40] BETA-BLOCKADE PREVENTS RECURRENT GASTROINTESTINAL-BLEEDING IN WELL-COMPENSATED PATIENTS WITH ALCOHOLIC CIRRHOSIS - A MULTICENTER RANDOMIZED CONTROLLED TRIAL [J].

COLOMBO, M ;

DEFRANCHIS, R ;

TOMMASINI, M ;

SANGIOVANNI, A ;

DIOGUARDI, N .

HEPATOLOGY, 1989, 9 (03) :433-438

← 1 2 3 4 5 →